These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 15562519)

  • 1. A molecular dynamics study of the structural stability of HIV-1 protease under physiological conditions: the role of Na+ ions in stabilizing the active site.
    Kovalskyy D; Dubyna V; Mark AE; Kornelyuk A
    Proteins; 2005 Feb; 58(2):450-8. PubMed ID: 15562519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural analysis of lead fullerene-based inhibitor bound to human immunodeficiency virus type 1 protease in solution from molecular dynamics simulations.
    Lee VS; Nimmanpipug P; Aruksakunwong O; Promsri S; Sompornpisut P; Hannongbua S
    J Mol Graph Model; 2007 Sep; 26(2):558-70. PubMed ID: 17468026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure, dynamics and solvation of HIV-1 protease/saquinavir complex in aqueous solution and their contributions to drug resistance: molecular dynamic simulations.
    Wittayanarakul K; Aruksakunwong O; Sompornpisut P; Sanghiran-Lee V; Parasuk V; Pinitglang S; Hannongbua S
    J Chem Inf Model; 2005; 45(2):300-8. PubMed ID: 15807491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Conformational changes in HIV-1 proteinase: effect of protonation of the active center on conformation of HIV-1 proteinase in water].
    Koval'skiĭ DB; Kanibolotskiĭ DS; Dubina VN; Korneliuk AI
    Ukr Biokhim Zh (1999); 2002; 74(6):135-8. PubMed ID: 12924029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural and dynamical properties of different protonated states of mutant HIV-1 protease complexed with the saquinavir inhibitor studied by molecular dynamics simulations.
    Aruksakunwong O; Wittayanarakul K; Sompornpisut P; Sanghiran V; Parasuk V; Hannongbua S
    J Mol Graph Model; 2006 Nov; 25(3):324-32. PubMed ID: 16504560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A molecular dynamics study comparing a wild-type with a multiple drug resistant HIV protease: differences in flap and aspartate 25 cavity dimensions.
    Seibold SA; Cukier RI
    Proteins; 2007 Nov; 69(3):551-65. PubMed ID: 17623840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computational study of IAG-nucleoside hydrolase: determination of the preferred ground state conformation and the role of active site residues.
    Mazumder-Shivakumar D; Bruice TC
    Biochemistry; 2005 May; 44(21):7805-17. PubMed ID: 15909995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational design of novel fullerene analogues as potential HIV-1 PR inhibitors: Analysis of the binding interactions between fullerene inhibitors and HIV-1 PR residues using 3D QSAR, molecular docking and molecular dynamics simulations.
    Durdagi S; Mavromoustakos T; Chronakis N; Papadopoulos MG
    Bioorg Med Chem; 2008 Dec; 16(23):9957-74. PubMed ID: 18996019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flap opening mechanism of HIV-1 protease.
    Tóth G; Borics A
    J Mol Graph Model; 2006 May; 24(6):465-74. PubMed ID: 16188477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unraveling HIV protease flaps dynamics by Constant pH Molecular Dynamics simulations.
    Soares RO; Torres PHM; da Silva ML; Pascutti PG
    J Struct Biol; 2016 Aug; 195(2):216-226. PubMed ID: 27291071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A combined quantum/classical molecular dynamics study of the catalytic mechanism of HIV protease.
    Liu H; Müller-Plathe F; van Gunsteren WF
    J Mol Biol; 1996 Aug; 261(3):454-69. PubMed ID: 8780786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on flexibility and binding affinity of Asp25 of HIV-1 protease mutants.
    Purohit R; Rajasekaran R; Sudandiradoss C; George Priya Doss C; Ramanathan K; Rao S
    Int J Biol Macromol; 2008 May; 42(4):386-91. PubMed ID: 18367244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition and catalytic mechanism of HIV-1 aspartic protease.
    Silva AM; Cachau RE; Sham HL; Erickson JW
    J Mol Biol; 1996 Jan; 255(2):321-46. PubMed ID: 8551523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cooperative fluctuations of unliganded and substrate-bound HIV-1 protease: a structure-based analysis on a variety of conformations from crystallography and molecular dynamics simulations.
    Kurt N; Scott WR; Schiffer CA; Haliloglu T
    Proteins; 2003 May; 51(3):409-22. PubMed ID: 12696052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A density functional study of the hydrogen-bond network within the HIV-1 protease catalytic site cleft.
    Sirois S; Proynov EI; Truchon JF; Tsoukas CM; Salahub DR
    J Comput Chem; 2003 Jul; 24(9):1110-9. PubMed ID: 12759910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular dynamics simulations of HIV-1 protease monomer: Assembly of N-terminus and C-terminus into beta-sheet in water solution.
    Yan MC; Sha Y; Wang J; Xiong XQ; Ren JH; Cheng MS
    Proteins; 2008 Feb; 70(3):731-8. PubMed ID: 17729281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions of the dimeric triad of HIV-1 aspartyl protease with inhibitors.
    Mager PP; De Clercq E; Froeyen M; Reinhardt R
    Drug Des Discov; 2003; 18(2-3):53-64. PubMed ID: 14675943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statistical and molecular dynamics studies of buried waters in globular proteins.
    Park S; Saven JG
    Proteins; 2005 Aug; 60(3):450-63. PubMed ID: 15937899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Theoretical study on the mechanism of a ring-opening reaction of oxirane by the active-site aspartic dyad of HIV-1 protease.
    Kóna J
    Org Biomol Chem; 2008 Jan; 6(2):359-65. PubMed ID: 18175006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the structure of HIV-1 protease complexed with a hexapeptide inhibitor. Part II: Molecular dynamic studies of the active site region.
    Geller M; Miller M; Swanson SM; Maizel J
    Proteins; 1997 Feb; 27(2):195-203. PubMed ID: 9061783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.